Millions of NHS patients are being denied migraine super drug

Millions of NHS patients are being denied migraine super drug Millions of Britons who suffer crippling migraines are being denied a cheap drug that could dramatically slash the number of debilitating attacks.

Migraine sufferers participating in studies using the drug have seen their headaches reduced, on average, from four a week to just one.

The drug, called flunarizine, is already the standard treatment in many other countries around the world for migraine, which affects one in seven Britons. But it is not licensed in the UK – though research shows the drug can work for patients who have failed to respond to up to six other drugs. The Daily Mail